Metabolomics of beta-blockers
Carvedilol is a nonselective β-blocker with multiple properties, including antioxidant properties, α-adrenergic blocking effects and inhibitory effects on calcium channels. It has been used in the clinical treatment of hypertension and congestive heart failure. While it is known that each enantiomer...
Saved in:
Main Author: | Tan, Ian Yong Ming. |
---|---|
Other Authors: | Chen Wei Ning, William |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/39680 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Membrane proteomics of cellular responses to β-blocker carvedilol
by: Wee, Kai Fa.
Published: (2010) -
Cellular response to synthetic drugs : a metabolomics approach
by: Chen, William Wei Ning.
Published: (2009) -
Proteomics and metabolomics analysis of cellular response to anti-coagulating drug warfarin
by: Bai, Jing
Published: (2011) -
Proteomics and metabolomics analysis of cellular responses to β-blocker carvedilol
by: Wang, Mingxuan
Published: (2012) -
Bioprocessing of human beta defensin-25
by: Tan, Alvin Leong Kiat.
Published: (2010)